Mihir Shah - May 19, 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role: Chief Financial Officer
Signature: /s/ Mark Hueppelsheuser, Attorney-in-Fact for Mihir Shah
Stock symbol: TOI
Transactions as of: May 19, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/19/2022, 06:43 PM
Previous filing: Apr 5, 2022
Next filing: Nov 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TOI	Class A Common Stock	Award	$0	+32.1K		$0.00	32.1K	May 19, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOI	Stock Options (right to buy)	Award	$0	+163K		$0.00	163K	May 19, 2022	Class A Common Stock	163K	$7.58	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") that vest in four equal annual installments on each of the first four anniversaries of May 19, 2022 (the "Vesting Commencement Date"), with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
F2	The stock options vest in four equal annual installments on each of the first four anniversaries of the Vesting Commencement Date, with all stock options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.